Related Experiment Video
Updated: Aug 11, 2026
06:32
Assessing Respiratory Immune Responses to Haemophilus Influenzae
Published on: June 29, 2021
rAAt (inhaled) Arriva/Hyland Immuno
1Paddock Laboratories Inc, 3940 Quebec Avenue North, Minneapolis, MN 55427, USA. wbrown@paddocklabs.com
Current Opinion in Molecular Therapeutics
|March 2, 2006
Summary
Arriva Pharmaceuticals and Hyland Immuno are developing a nebulized recombinant alpha1-antitrypsin (rAAT) therapy for respiratory conditions like emphysema and asthma. This innovative treatment is currently in phase II clinical trials.
Area of Science:
- Pulmonology
- Pharmacology
- Biotechnology
Background:
- Respiratory disorders such as emphysema, asthma, and COPD pose significant health challenges.
- Alpha1-antitrypsin deficiency is linked to lung damage and these conditions.
- Current treatments for these diseases have limitations.
Purpose of the Study:
- To evaluate the safety and efficacy of a nebulized formulation of recombinant alpha1-antitrypsin (rAAT).
- To explore rAAT as a potential therapeutic agent for various respiratory disorders.
Main Methods:
- Development of a nebulized formulation of rAAT.
- Conducting phase II clinical trials to assess the therapy in patients with respiratory conditions.
Main Results:
- The nebulized rAAT formulation is currently under investigation in phase II clinical trials.
- Preliminary data on efficacy and safety are expected from ongoing trials.
Conclusions:
- Nebulized rAAT represents a novel approach to treating respiratory diseases.
- Further clinical evaluation is required to establish its therapeutic potential.
Related Concept Videos
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...